Literature DB >> 23788480

Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.

Patricia Ruiz-Garbajosa1, Tania Curiao, Marta Tato, Desirèe Gijón, Vicente Pintado, Aránzazu Valverde, Fernando Baquero, María Isabel Morosini, Teresa M Coque, Rafael Cantón.   

Abstract

OBJECTIVES: To analyse the ongoing epidemiology of KPC-producing Enterobacteriaceae after a non-ST258 KPC-3-producing Klebsiella pneumoniae outbreak in a university hospital in Madrid, Spain.
METHODS: Enterobacterial isolates (one per patient based on bacterial identification and typing patterns) with carbapenem MICs higher than the EUCAST epidemiological cut-off values, a positive modified Hodge test and carbapenem/boronic acid combination disc test results were studied (16 March 2010 to 31 January 2012) and compared with KPC-producing isolates previously described in our institution (September 2009 to February 2010). The bacterial population structure (PFGE and multilocus sequence typing), carbapenemase genes and KPC plasmids were studied. Patients' clinical records were reviewed.
RESULTS: Twenty-four KPC-producing Enterobacteriaceae (20 K. pneumoniae, 2 Escherichia coli and 2 Enterobacter cloacae) from 23 patients (13 males, median age 72 years) were studied. Most KPC-producer strains were considered as colonizers. Six K. pneumoniae clones (ST11, ST20, ST384, ST454, ST659 and ST971), two E. coli clones (ST224 and ST357) and one E. cloacae clone were identified. blaKPC-3 was located on IncFIIK plasmids of ∼100 kb (E. coli ST357 and K. pneumoniae ST384, ST454, ST659 and ST971 clones) and on IncN plasmids of ∼40 kb (K. pneumoniae ST11 clone). Non-typeable plasmids of ∼20 kb containing blaKPC-2 were detected in scarcely represented clones (K. pneumoniae ST20, E. coli ST224 and E. cloacae).
CONCLUSIONS: During the 2 year period following the emergence of non-ST258 KPC-3-producing K. pneumoniae isolates in our institution, the blaKPC-3 and blaKPC-2 genes efficiently penetrated other Enterobacteriaceae lineages. Non-ST258 K. pneumoniae isolates were mostly responsible for the dissemination of KPC enzymes, producing a complex epidemiological picture.

Entities:  

Keywords:  IncFIIK plasmids; carbapenem resistance; carbapenemase-producing Enterobacteriaceae

Mesh:

Substances:

Year:  2013        PMID: 23788480     DOI: 10.1093/jac/dkt237

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Detection of Carbapenemase Production in a Collection of Enterobacteriaceae with Characterized Resistance Mechanisms from Clinical and Environmental Origins by Use of Both Carba NP and Blue-Carba Tests.

Authors:  Sergio García-Fernández; María-Isabel Morosini; Desirèe Gijón; Lorena Beatobe; Patricia Ruiz-Garbajosa; Lucas Domínguez; Rafael Cantón; Aránzazu Valverde
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

2.  Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic βLacta test.

Authors:  María Isabel Morosini; María García-Castillo; Marta Tato; Desirèe Gijón; Aránzazu Valverde; Patricia Ruiz-Garbajosa; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

3.  Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.

Authors:  Jesús Oteo; Adriana Ortega; Rosa Bartolomé; Germán Bou; Carmen Conejo; Marta Fernández-Martínez; Juan José González-López; Laura Martínez-García; Luis Martínez-Martínez; María Merino; Elisenda Miró; Marta Mora; Ferran Navarro; Antonio Oliver; Álvaro Pascual; Jesús Rodríguez-Baño; Guillermo Ruiz-Carrascoso; Patricia Ruiz-Garbajosa; Laura Zamorano; Verónica Bautista; María Pérez-Vázquez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  Elucidating constraints for differentiation of major human Klebsiella pneumoniae clones using MALDI-TOF MS.

Authors:  C Rodrigues; Â Novais; C Sousa; H Ramos; T M Coque; R Cantón; J A Lopes; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-03       Impact factor: 3.267

5.  The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.

Authors:  Jesús Oteo; María Pérez-Vázquez; Verónica Bautista; Adriana Ortega; Pilar Zamarrón; David Saez; Sara Fernández-Romero; Noelia Lara; Raquel Ramiro; Belén Aracil; José Campos
Journal:  J Antimicrob Chemother       Date:  2016-08-15       Impact factor: 5.790

Review 6.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

7.  Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014.

Authors:  Nicole Stoesser; Hang T T Phan; Anna C Seale; Zoie Aiken; Stephanie Thomas; Matthew Smith; David Wyllie; Ryan George; Robert Sebra; Amy J Mathers; Alison Vaughan; Timothy E A Peto; Matthew J Ellington; Katie L Hopkins; Derrick W Crook; Alex Orlek; William Welfare; Julie Cawthorne; Cheryl Lenney; Andrew Dodgson; Neil Woodford; A Sarah Walker
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 8.  Carbapenemase-producing Enterobacteriaceae.

Authors:  Yohei Doi; David L Paterson
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

9.  In Silico Typing and Comparative Genomic Analysis of IncFIIK Plasmids and Insights into the Evolution of Replicons, Plasmid Backbones, and Resistance Determinant Profiles.

Authors:  Dexi Bi; Jiayi Zheng; Jun-Jie Li; Zi-Ke Sheng; Xingchen Zhu; Hong-Yu Ou; Qianyu Li; Qing Wei
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

10.  KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region.

Authors:  Jacqueline Findlay; Katie L Hopkins; Michel Doumith; Danièle Meunier; Camilla Wiuff; Robert Hill; Rachel Pike; Richard Loy; Nazim Mustafa; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2016-02-03       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.